Ganoderma Lucidum Spore Oil Softgel (Reishi mushroom spore oil softgel) uses organic shell-broken Ganoderma
spore powder as ingredients, combined with our patented supercritical CO2 extraction
technology, making it the ultimate Ganoderma dietary supplement product on the
market with the highest purity.
When it comes to
dietary supplement product, safety is always the top priority. Our Ganoderma
ingredient comes from our self-built Ganoderma farm, which has acquired 4
organic certifications from China, Japan, the US, and the EU. We make sure
every step of the whole process is safe
and traceable without any kind of contamination.
The supercritical
CO2 extraction technology uses liquefied CO2 as a solvent to dissolve spore oil from shell-broken
spore powder under hyperbaric environment. After CO2 evaporates, it
is left with pure Reishi Spore Oil. This
method makes sure that no chemical reagent will be left in the spore oil during
the extraction process while still maintaining the highest purity. The
triterpenes content in this product is as high as over 20%.
Ganoderma spore
oil is great for people with severe chemical liver damage due to long-term drinking
and high pressure. It also assists cancer treatment and helps reduce the side
effects from chemo and radiotherapy and
greatly increase the level of immune cells. Reports have shown that Ganoderma Oil can inhibit the growth of internal and external tumor, with a success
rate of 56.3%.
Recommended
dosage: 2 times a day, 2 capsules each time.
Ganoderma Lucidum Spore Oil Softgel,Reishi Spore Oil,Ganoderma Oil Ganoherb International Inc. , http://www.ganoherb.us
The highest retail price of 3,000 drugs in Hebei announced 173 proprietary Chinese medicines
Business News Agency Aug. 2 hearing Recently, the (Hebei) Provincial Price Bureau reassessed the results of the successful bid of the provincial government's leading group office for drug procurement, and announced to the public the basic version of the national basic drug 2010 in our province (directly linked to the The highest retail price of some parts), the new price will be implemented from July 28. Among them, there are 2,894 chemical and biological products and 173 proprietary Chinese medicines.
According to the “< Hebei Province Medical Institutions Purchasing Measures for the Centralized Purchasing of Drugs (Trial)> Supplementary Provisionsâ€, the Provincial Price Bureau requires the local health administrative departments to promptly report to the local price authority for the actual purchase price determined through negotiation. The basic medical and health institutions of the basic drug system shall use a zero margin rate of sales based on the actual purchase prices determined by the health administrations at various levels through bargaining. When other medical institutions sell these drugs, the actual price increase rate shall not exceed 15% of the maximum retail price.
It is understood that there are 59 counties (cities, districts) in the province that have implemented the basic drug system in the first batch (see the second edition of this report on June 25th). The Provincial Price Bureau requires all relevant departments to strengthen the zero rate of basic drugs. After the sale of medical institutions, the actual purchase of varieties, quantity, structure and price monitoring analysis. For the actual transaction price and the provincial purchase price difference is very different, or the price adjustment after the market supply is tight, we must promptly to the Provincial Price Bureau, the provincial Health Department Feedback.
In order to ensure that the newly published national zero-difference sales rate for essential medicines is in place, price authorities at all levels will carry out a special inspection in the near future and raise the prices for violations of laws and regulations. Units that do not implement zero-dip sales of drugs must be severely investigated and dealt with according to law. Typical cases are required. Public exposure.